MTOR and renal cell carcinoma: In this study, a novel mechanism is proposed, where BCKDK promotes tumorigenesis in RCC by directly mediating downstream AKT phosphorylation at Ser473 and Thr308, thereby activating the AKT/mTOR pathway.